1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. GENMAB - ADR
Genmab - ADR
XNAS: GMAB

Genmab (ADR) Live Stock Price Today, Share Analysis and Chart

Mid-range Performer
about

Genmab is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer. Genmab's proprietary antibody technologies are DuoBody, HexaBody, DuoHexaBody, and HexElect. Johnson & Johnson partnered with Genmab...

Read More
26.14 -0.43 (-1.62%)
26.22% Fall from 52W High
1.0M
XNAS Volume

XNAS 13 Mar, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Genmab (ADR) is on 19 Mar 2026 for the purpose of Genmab AS Annual General Meeting for 2026 See details
Durability score
Medium Financial Strength
38.9 / 100
Valuation Score
Mid Valuation
44.3 / 100
Momentum Score
Technically Neutral
41.9 / 100
Mid-range Performer These stocks have average quality, financial and technical momentum, indicating a mid range performer View Similar Embed DVM
Analyst Price Target
38
1Yr Price target upside is 44%
10 analysts

6

S

9

W

5

O

0

T

SWOT Analysis

Genmab (ADR) Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..